WP
BCYC

Woodline Partners’s Bicycle Therapeutics BCYC Stock Holding History

Woodline Partners’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-362,325
Closed -$2.52M – 891
2025
Q2 		$2.52M Sell
362,325
-1,426
-0.4% -$11.4K 0.01% 693
2025
Q1 		$3.09M Buy
+363,751
New +$4.29M 0.02% 604
2024
Q3 		– Sell
-586,622
Closed -$11.9M – 606
2024
Q2 		$11.9M Buy
+586,622
New +$13.3M 0.11% 230
2022
Q2 		– Sell
-17,954
Closed -$788K – 803
2022
Q1 		$788K Buy
+17,954
New +$838K 0.01% 489

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Woodline Partners's BCYC Position: Q3 2025 in Review

Woodline Partners sold out of Bicycle Therapeutics (BCYC) in Q3 2025, closing a stake of 362,325 shares — an estimated $2.52M sold.

Woodline Partners first reported a position in BCYC in Q1 2022 and held it in 4 quarters. The position peaked at $11.9M in Q2 2024. 99 funds tracked by Wall St. Rank hold BCYC as of Q3 2025.

  • Woodline Partners reported no remaining Bicycle Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Woodline Partners sold 362,325 Bicycle Therapeutics shares in Q3 2025, an estimated $2.52M.
  • Woodline Partners first reported a position in Bicycle Therapeutics in Q1 2022 and held it in 4 quarters.
  • Woodline Partners's Bicycle Therapeutics position peaked at $11.9M in Q2 2024.
  • 99 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2025.

Based on Woodline Partners's 13F filing for Q3 2025, filed 14 Nov 2025.